ly 134046 has been researched along with saralasin in 1 studies
| Studies (ly 134046) | Trials (ly 134046) | Recent Studies (post-2010) (ly 134046) | Studies (saralasin) | Trials (saralasin) | Recent Studies (post-2010) (saralasin) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 1,497 | 13 | 16 |
| Protein | Taxonomy | ly 134046 (IC50) | saralasin (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0006 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganong, WF; Steele, MK | 1 |
1 other study(ies) available for ly 134046 and saralasin
| Article | Year |
|---|---|
Effects of catecholamine-depleting agents and receptor blockers on basal and angiotensin II- or norepinephrine-stimulated luteinizing hormone release in female rats.
Topics: Angiotensin II; Animals; Benzazepines; Catecholamines; Ditiocarb; Dopamine beta-Hydroxylase; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Ovariectomy; Phenylethanolamine N-Methyltransferase; Prazosin; Propranolol; Rats; Saralasin; Yohimbine | 1986 |